Evidence suggested that GBM with IDH1 mutation represents a distinct disease entity characterized by a different clinical behavior: it emerges in the frontal lobe in young individuals and has a significantly longer PSF and OS [34]. The gene discussed is IDH1; the disease is glioblastoma.